t
BSF Enterprise PLC announced on 13 March 2026 the mutual termination of its proposed £15m Equity Fundraise and Capital Reorganisation. Concurrently, a £300K Convertible Loan Note will continue under its existing terms, extended for 12 months, with repayment in cash or conversion at the next BSF capital raise price. The Company has also entered discussions with other parties for alternative fundraising at Group and subsidiary levels.
| Date | 13 Mar 2026 |
| Time | 07:00:07 |
| Category | Miscellaneous |
| ID | 4662W |
13 March 2026
BSF Enterprise PLC
("BSF" or the "Company")
Further Update on Proposed £15m Equity Fundraise and Capital Reorganisation
Further to the Company's announcement on 27 February 2026 the Company provides an update on the previously announced Equity Fundraise and Capital Reorganisation. Capitalised terms used in this announcement have the same meanings as in the earlier announcement unless the context requires otherwise.
The Equity Fundraise for £15m and proposed Capital Reorganisation has been mutually terminated between the parties and each party will seek to terminate all relevant agreements that formed part of the transaction.
However the CLN of £300K will continue on the same terms but be extend for 12 months and then repaid in cash or the CLN noteholders have a right to convert over that period at next BSF capital raise price.
Further to the above, the Company confirms that it will seek alternative fundraising options and it has entered discussions with other parties to raise funds both at Group level and subsidiary level for Lab-grown Leather Ltd and Kerato Ltd.
This process remains ongoing and the Company is seeking to close a new favourable fundraising option in the coming weeks. The Company will provide further updates as appropriate.
END
Engage with the BSF Enterprise management team directly by asking questions, watching video
summaries and seeing what other shareholders have to say. Navigate to our Interactive Investor
website here:
https://bsfenterprise.com/link/ya3gRr
For further enquiries, please visit www.bsfenterprise.com or contact:
|
BSF Enterprise PLC Geoff Baker - Chairman Che Connon - CEO & Director
We encourage all investors to share questions on this announcement via our investor website. |
|
|
Shard Capital (Broker) Damon Heath Isabella Pierre |
(0)20 4530 6926 (0)20 4530 6928 |
|
AlbR Capital Limited (Broker) Colin Rowbury Jon Belliss |
+44 (0)20 7469 0930 |
|
ISIN of the Ordinary Shares is GB00BHNBDQ51. SEDOL Code is BHNBDQ5. |
|
Subscribe to our news alert service: https://bsfenterprise.com/s/bb9f43
About BSF Enterprise PLC
BSF Enterprise PLC (BSF) develops and commercialises cutting-edge tissue-engineered solutions, including lab-grown leather, cultivated meat, and corneal repair technologies. By leveraging its proprietary scaffold-free platform, BSF aims to deliver sustainable alternatives to traditional materials and meet global demand for environmentally responsible innovations.